2m 2m 2m 2m 2m 2m 2m
ALZAMEND (ALZN)
NASDAQ
$1.36-$0.01 (-0.73%)
Price as of Jun 24, 2026 4:43 PM EDT- $5.2MMarket Cap
- -53.24%1-Year Change
- BiotechnologyIndustry
ALZAMEND (ALZN)
$1.36-$0.01 (-0.73%)
ALZN | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $1.37 | ||
Change | +$0.15 (+12.30%) | ||
Open | $1.18 | ||
High | $1.37 | ||
Low | $1.18 | ||
Previous Close | $1.22 | ||
Volume | 360,288 | ||
30-Day Average Volume | 71,660 | ||
1-Week Change | 7.03% | ||
1-Month Change | 21.24% | ||
1-Year Change | -53.24% | ||
3-Year Change | -99.82% | ||
5-Year Change | -99.99% | ||
Fundamentals | |||
Shares Outstanding | 3.8M | ||
Total Assets | $4.0M | ||
Market Cap | $5.2M | ||
Enterprise Value | $2.5M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$2.2M | ||
Free Cash Flow | -$1.7M | ||
EBIT | -$2.2M | ||
EBITDA | -$2.2M | ||
Net Working Capital | $1.8M | ||
EPS | -$0.58 | ||
Enterprise Value/EBITDA | -1 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 2 | ||
P/E | -2 | ||
PEG | 0 | ||
Price/Free Cash Flow | -3 | ||
Price/Operating Cash Flow | -3 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 9 | ||
Last Split Date | 05/12/2025 | ||